calendar
2 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
2 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.